Demystifying Universal Health Servs: Insights From 12 Analyst Reviews
Portfolio Pulse from Benzinga Insights
12 analysts have recently reviewed Universal Health Servs (NYSE:UHS), showing a diverse range of opinions from bullish to bearish. The average 12-month price target for UHS has been raised to $181.25, indicating a 12.11% increase from the previous target. Analysts from firms like Wells Fargo, JP Morgan, and RBC Capital have adjusted their ratings and price targets, reflecting a generally positive outlook on UHS's financial performance, which includes a revenue growth of 7.44% and a net margin of 5.84%.
March 28, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Universal Health Servs has received updated analyst ratings and price targets, with an average 12-month price target of $181.25, reflecting a positive outlook on the company's financial performance.
The increase in the average price target to $181.25, along with positive adjustments in ratings and price targets by analysts from reputable firms, indicates a bullish sentiment towards UHS. This is further supported by UHS's reported revenue growth and above-average financial metrics such as net margin and ROE, suggesting a strong financial performance that could drive the stock price up in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100